Nitrogen-containing heterocyclic compounds as fxr modulators
AssigneeHepagene Therapeutics (HK) Limited
InventorXiaodong Xu
Life of this patent
Estimating the term…
Abstract
The present technology is directed to compounds, compositions, and methods related to modulation of FXR. In particular, the present compounds and compositions may be used to treat FXR-mediated disorders and conditions, including, e.g., liver disease, hyperlipidemia, hypercholesteremia, obesity, metabolic syndrome, cardiovascular disease, gastrointestinal disease, and atherosclerosis, and renal disease.
Claims34
A compound according to formula I
- stereoisomers, and/or salts thereof wherein
- L and M are independently selected from N and CR7, provided that at least one of L and M is N;
- Z is a substituted or unsubstituted C1-C4 alkylene group;
- W is
- X is
- D is N or CR9;
- G4 is CR13;
- G1, G2, G3 are selected from the group consisting of CH and CR11;
- Q is O, S, or NR12;
- R1 and R2 are independently H, OH, halo, CN, carboxyl, NRaRb, or a substituted or unsubstituted alkyl, alkoxy, or hydroxyalkyl group;
- R3 is a substituted or unsubstituted alkyl or cycloalkyl group;
- R4 is CN, SO3H, CONRaRb, SO2NRaRb, NHSO2Rb, SO2NHCORa, CO2Rc, or a substituted or unsubstituted tetrazolyl or 1,2,4-oxadiazol-5(4H)-one-3-yl group;
- R7 is H, OH, halo, CN, carboxyl, amido, NRaRb, or a substituted or unsubstituted alkyl, alkoxy, hydroxyalkyl, or aminoalkyl group;
- R9 is H, halo, or a substituted or unsubstituted C1-C6 alkyl, or O—(C1-C6 alkyl) group;
- R10 at each occurrence is independently halo, CO2Rc, or a substituted or unsubstituted alkyl, alkoxy, hydroxyalkyl, cycloalkyl, or fluorinated cycloalkyl group, or, when n is 2 or 3, two of the R10 groups together may be a substituted or unsubstituted C2-C5 alkylene, heteroalkylene, alkenylene or heteroalkenylene group having 2 separate points of attachment to the same carbon or different carbons of the nitrogen containing ring to which it is attached;
- R11 at each occurrence is independently OH, halo, CF3, CN, carboxyl, NRaRb, or a substituted or unsubstituted alkyl, alkoxy group, or phenyl group;
- R12 is H or a substituted or unsubstituted C1-C6 alkyl group;
- and
- R13 is halo, or a substituted or unsubstituted C1-C6 alkyl, or O—(C1-C6 alkyl) group;
- Ra at each occurrence is independently H, or a substituted or unsubstituted alkyl, haloalkyl, cycloalkyl, aryl, or SO2-alkyl group;
- Rb at each occurrence is H or a substituted or unsubstituted alkyl, or haloalkyl group;
- Rc is H or a substituted or unsubstituted alkyl, alkenyl, alkynyl, or cycloalkyl group;
- n is 0, 1, 2, 3, or 4;
- and
- r and t are each independently 1, 2, or 3.
A compound selected from the group consisting of compounds II-17, II-30, II-36, II-37, II-38, II-39, II-43, II-44, II-45, I-46, II-47, II-48, II-49, I-50, II-51, III-08, IV-10, and VI-11.
Dependencies are inferred from the claim text.